Addressing Innovation in Prenatal Screening

Following rapid innovation in non-invasive prenatal testing (NIPT), ASHG and the European Society of Human Genetics published a joint statement in the European Journal of Human Genetics that addressed the responsible use of these tests across conditions and how they might fit with existing approaches.

Related:

• Statement: Non-invasive Prenatal Testing for Aneuploidy and Beyond: Challenges of Responsible Innovation in Prenatal Screening (March 2015)
• Press Release: ASHG and ESHG Issue Position Statement on Non-Invasive Prenatal Screening (March 2015)